CLL
Showing 26 - 43 of 43
The Capability of Haemato-oncology Patients to Generate
Active, not recruiting
- CLL
- +2 more
-
Tel Aviv, IsraelTel-Aviv Sourasky Medical Center
Aug 8, 2021
Leukemia, CLL Trial in Houston (Lenalidomide)
Completed
- Leukemia
- CLL
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 30, 2021
Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, AML, Adult Trial in Orange (Pitavastatin, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- +5 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Mar 25, 2021
Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,
Completed
- Blood Cancer
- +7 more
- non-myeloablative hematopoietic cell transplantation
- +8 more
-
Stanford, CaliforniaStanford University School of Medicine
Nov 17, 2019
Chronic Lymphocytic Leukemia Electronic Patient Reported
Completed
- CLL
- Carevive CPS
-
Tampa, FloridaMoffitt Cancer Institute
Aug 23, 2019
Allogeneic Hematopoietic Stem Cell Transplantation in 17p-
Completed
- CLL
-
Copenhagen, Denmark
- +9 more
Aug 14, 2019
Leukemia, CLL, Chronic Lymphocytic Leukemia Trial in Houston (Lenalidomide)
Completed
- Leukemia
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Jul 23, 2018
Safety of Chlorambucil + Rituximab in CLL Patients
Unknown status
- CLL
- +4 more
-
Ascoli Piceno, Italy
- +19 more
Mar 21, 2018
Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (radiation, biological, drug)
Terminated
- Hematologic Malignancy
- +11 more
- Total Body Irradiation (TBI)
- +5 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Oct 19, 2016
AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)
Completed
- AML
- +8 more
- Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jul 14, 2016
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, CLL Trial in La Jolla (A6)
Terminated
- Chronic Lymphocytic Leukemia
- +3 more
-
La Jolla, CaliforniaMoores Cancer Center, UCSD
Jul 11, 2016
Peptide-drug-conjugates for Personalized, Targeted Therapy of
Unknown status
- CLL
- there will be no intervention.
- (no location specified)
Jul 7, 2016
CLL, Chronic Lymphocytic Leukemia Trial in Innsbruck, Salzburg (Lenalidomide)
Completed
- CLL
- Chronic Lymphocytic Leukemia
-
Innsbruck, Tirol, Austria
- +1 more
May 25, 2016
Heavy Light Chain in Chronic Lymphocytic Leukemia
Unknown status
- CLL
- No intervantion
-
Haifa, IsraelBnai Zion Medical Center
Feb 25, 2015
Chronic Lymphocytic Leukemia, CLL, Untreated Trial in United States (Lenalidomide and Rituximab)
Unknown status
- Chronic Lymphocytic Leukemia
- +5 more
- Lenalidomide and Rituximab
-
La Jolla, California
- +4 more
Sep 8, 2010
Chronic Lymphocytic Leukemia, CLL Trial in New Hyde Park, Houston, San Antonio (Oblimerson sodium, G3139)
Completed
- Chronic Lymphocytic Leukemia
- CLL
- Oblimerson sodium, G3139
-
New Hyde Park, New York
- +2 more
Nov 10, 2009